nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—Ketoprofen—CXCL8—Crohn's disease	0.031	0.644	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—Crohn's disease	0.00903	0.188	CrCbGaD
Bopindolol—Ketoprofen—ALB—Crohn's disease	0.00805	0.167	CrCbGaD
Bopindolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00345	0.00363	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00344	0.00361	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCR9—Crohn's disease	0.00342	0.00359	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00338	0.00355	CbGpPWpGaD
Bopindolol—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00338	0.00355	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00336	0.00353	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00329	0.00345	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CCR6—Crohn's disease	0.00329	0.00345	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.00322	0.00338	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—GPR65—Crohn's disease	0.00318	0.00334	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.00315	0.00331	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.00309	0.00324	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—MLN—Crohn's disease	0.00308	0.00324	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—ACKR2—Crohn's disease	0.00307	0.00323	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00303	0.00318	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.00302	0.00317	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00296	0.00311	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—ACKR2—Crohn's disease	0.00295	0.0031	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.00292	0.00307	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MLN—Crohn's disease	0.00291	0.00306	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00289	0.00304	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—PTGER4—Crohn's disease	0.00289	0.00304	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.00286	0.00301	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CCR9—Crohn's disease	0.0028	0.00294	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—MLN—Crohn's disease	0.0028	0.00294	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TAGAP—Crohn's disease	0.00266	0.0028	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.00262	0.00275	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—GPR65—Crohn's disease	0.00261	0.00274	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.00256	0.00269	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCR9—Crohn's disease	0.00255	0.00267	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CCR6—Crohn's disease	0.0025	0.00263	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CCR6—Crohn's disease	0.00249	0.00262	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—GPR65—Crohn's disease	0.00237	0.00249	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RSPO3—Crohn's disease	0.00233	0.00244	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.0023	0.00242	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ACKR2—Crohn's disease	0.00229	0.0024	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CCR6—Crohn's disease	0.00226	0.00238	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.00225	0.00237	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.00223	0.00235	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SEL1L—Crohn's disease	0.00221	0.00232	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—PTGER4—Crohn's disease	0.0022	0.00231	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00219	0.0023	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.00218	0.00229	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MLN—Crohn's disease	0.00217	0.00228	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CCR9—Crohn's disease	0.00214	0.00224	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.00208	0.00218	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.00203	0.00213	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.00203	0.00213	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCR9—Crohn's disease	0.00202	0.00212	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—PTGER4—Crohn's disease	0.00199	0.00209	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—GPR65—Crohn's disease	0.00199	0.00209	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TAGAP—Crohn's disease	0.00198	0.00208	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.00198	0.00208	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	0.00194	0.00204	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	0.00188	0.00198	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—GPR65—Crohn's disease	0.00188	0.00197	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—IL3—Crohn's disease	0.00187	0.00196	CbGpPWpGaD
Bopindolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00187	0.00196	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CCR6—Crohn's disease	0.00186	0.00195	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00185	0.00194	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.00184	0.00194	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	0.00182	0.00191	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00181	0.0019	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	0.0018	0.00189	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.00178	0.00187	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00177	0.00186	CbGpPWpGaD
Bopindolol—HTR1B—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00175	0.00184	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	0.00174	0.00183	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RSPO3—Crohn's disease	0.00173	0.00182	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MLN—Crohn's disease	0.00173	0.00182	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL3—Crohn's disease	0.0017	0.00178	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.00169	0.00178	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CCR6—Crohn's disease	0.00169	0.00177	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MLN—Crohn's disease	0.00165	0.00174	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SEL1L—Crohn's disease	0.00164	0.00173	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—RASGRP1—Crohn's disease	0.00164	0.00172	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00163	0.00172	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	0.00158	0.00166	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.00155	0.00162	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	0.00151	0.00159	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCR9—Crohn's disease	0.0015	0.00158	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PTGER4—Crohn's disease	0.00148	0.00156	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	0.00148	0.00155	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00145	0.00152	CbGpPWpGaD
Bopindolol—ADRB3—GPCR ligand binding—CXCL8—Crohn's disease	0.00142	0.00149	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00141	0.00149	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GPR65—Crohn's disease	0.0014	0.00147	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—IL3—Crohn's disease	0.00139	0.00146	CbGpPWpGaD
Bopindolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00139	0.00146	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	0.00138	0.00145	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.00135	0.00142	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00135	0.00141	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	0.00134	0.00141	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCR6—Crohn's disease	0.00134	0.0014	CbGpPWpGaD
Bopindolol—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00133	0.0014	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.00132	0.00139	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.00131	0.00138	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	0.00131	0.00138	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—IL2RA—Crohn's disease	0.00131	0.00137	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	0.0013	0.00137	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00129	0.00135	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	0.00128	0.00135	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.00128	0.00135	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00127	0.00134	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL3—Crohn's disease	0.00126	0.00133	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	0.00125	0.00132	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00125	0.00131	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—RASGRP1—Crohn's disease	0.00122	0.00128	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RBX1—Crohn's disease	0.00121	0.00127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	0.0012	0.00126	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL2RA—Crohn's disease	0.00119	0.00125	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	0.00118	0.00124	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PTGER4—Crohn's disease	0.00118	0.00124	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.00117	0.00123	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.00116	0.00121	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR9—Crohn's disease	0.00115	0.0012	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	0.00113	0.00119	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	0.00111	0.00117	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	0.00111	0.00116	CbGpPWpGaD
Bopindolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00111	0.00116	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.00109	0.00114	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.00108	0.00114	CbGpPWpGaD
Bopindolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00108	0.00114	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00107	0.00113	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GPR65—Crohn's disease	0.00106	0.00112	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	0.00106	0.00111	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—UBE2D1—Crohn's disease	0.00106	0.00111	CbGpPWpGaD
Bopindolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00106	0.00111	CbGpPWpGaD
Bopindolol—HTR1B—GPCR ligand binding—CXCL8—Crohn's disease	0.00106	0.00111	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00105	0.0011	CbGpPWpGaD
Bopindolol—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.00104	0.00109	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RIPK2—Crohn's disease	0.00103	0.00108	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00103	0.00108	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	0.00101	0.00106	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL3—Crohn's disease	0.001	0.00105	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCR6—Crohn's disease	0.000996	0.00105	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.000985	0.00103	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000975	0.00102	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000974	0.00102	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RASGRP1—Crohn's disease	0.000969	0.00102	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.000963	0.00101	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000953	0.001	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000932	0.000979	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RBX1—Crohn's disease	0.000901	0.000946	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000886	0.000931	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—JAK2—Crohn's disease	0.00088	0.000924	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SOCS1—Crohn's disease	0.000878	0.000923	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PTGER4—Crohn's disease	0.000877	0.000921	CbGpPWpGaD
Bopindolol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	0.000843	0.000886	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—TYK2—Crohn's disease	0.000837	0.00088	CbGpPWpGaD
Bopindolol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.000825	0.000867	CbGpPWpGaD
Bopindolol—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000807	0.000847	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000803	0.000843	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—JAK2—Crohn's disease	0.000799	0.000839	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	0.000793	0.000833	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	0.00079	0.00083	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000777	0.000816	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.000776	0.000815	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	0.000766	0.000805	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00076	0.000798	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR6—Crohn's disease	0.000759	0.000797	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	0.000758	0.000797	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL3—Crohn's disease	0.000747	0.000785	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000743	0.000781	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	0.000729	0.000766	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000722	0.000759	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	0.000717	0.000754	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	0.000705	0.000741	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	0.000702	0.000738	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.000702	0.000737	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	0.000698	0.000734	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.00069	0.000725	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RBX1—Crohn's disease	0.000686	0.000721	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000683	0.000718	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000675	0.000709	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	0.000668	0.000702	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000656	0.000689	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	0.000655	0.000688	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	0.000629	0.000661	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	0.000624	0.000656	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000615	0.000646	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	0.00061	0.000641	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000602	0.000632	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000598	0.000629	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	0.000597	0.000627	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	0.000595	0.000625	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL3—Crohn's disease	0.000595	0.000625	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	0.000584	0.000613	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL3—Crohn's disease	0.000582	0.000611	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	0.000575	0.000604	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL3—Crohn's disease	0.000569	0.000598	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	0.000565	0.000594	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000563	0.000591	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	0.00055	0.000578	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000543	0.000571	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	0.000523	0.00055	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	0.000522	0.000549	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	0.000521	0.000548	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	0.000511	0.000537	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	0.00051	0.000536	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000499	0.000525	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	0.000499	0.000524	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	0.000497	0.000522	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TYK2—Crohn's disease	0.000495	0.00052	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	0.000486	0.000511	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000477	0.000501	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	0.000475	0.000499	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	0.000474	0.000498	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—JAK2—Crohn's disease	0.000472	0.000496	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000466	0.00049	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	0.000464	0.000487	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000456	0.000479	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	0.000454	0.000476	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	0.00045	0.000473	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	0.00044	0.000462	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	0.000433	0.000455	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	0.000431	0.000452	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	0.000431	0.000452	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	0.000423	0.000445	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	0.000417	0.000438	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000414	0.000435	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—Crohn's disease	0.00041	0.00043	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	0.000408	0.000428	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	0.000399	0.000419	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TYK2—Crohn's disease	0.000369	0.000387	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—JAK2—Crohn's disease	0.000352	0.000369	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—STAT3—Crohn's disease	0.000346	0.000364	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	0.000321	0.000337	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—Crohn's disease	0.000305	0.000321	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	0.000294	0.000308	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	0.000287	0.000302	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TYK2—Crohn's disease	0.000281	0.000295	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	0.00028	0.000294	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	0.000274	0.000288	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—JAK2—Crohn's disease	0.000268	0.000281	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—STAT3—Crohn's disease	0.000258	0.000271	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	0.000256	0.000269	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	0.00025	0.000263	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	0.000245	0.000257	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	0.000243	0.000255	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—Crohn's disease	0.000242	0.000254	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	0.000238	0.00025	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—Crohn's disease	0.000233	0.000244	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	0.000206	0.000216	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	0.000201	0.000211	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—STAT3—Crohn's disease	0.000197	0.000207	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—Crohn's disease	0.00018	0.000189	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—Crohn's disease	0.000144	0.000151	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—Crohn's disease	0.00014	0.000148	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—Crohn's disease	0.000137	0.000144	CbGpPWpGaD
